50 Partners

Address the critical bottlenecks in both established and emerging markets that limit access and affordability to novel cancer solutions. Inculcate the tenets of ESG (Environmental, Social and Governance) based investing and measure the progress and impact of our portfolio using the following metrics: E: The ability to optimize differential drug and device pricing based on geography and expand access to promising products early in their lifecycle S: Ability to boost R&D productivity through operational optimization and process transformation G: Promote ethical conduct of business and collaboration while ensuring inclusion & diversity What We DoInvest in US and EU based cancer start-ups who are keen to explore emerging markets or engage in collaborative R&D. Streamline the product-market fit and ensure access to supportive infrastructure and resources. Facilitate their collaborative R&D/commercialization strategy in geographies of interest. How We Do It Accelerate the path to successful commercialization for US and EU based start-ups developing the next generation of oncology solutions by: Reducing costs through infrastructure consolidation and collaborative expertise Expanded access to capital Facilitating rapid market penetration and commercial scaling​

Our Ventures team supports the launch of startups based on University of Michigan technologies and research discoveries. We provide a full suite of resources, services and funding to help you launch sustainable, impactful world changing startups. The Ventures team will engage with you from day one to establish clear and executable commercialization, business formation and funding strategies. As your startup project begins to take form we can provide grant funding and investment capital, as well as business know-how, talent resources and connections to a nationwide network of investors. Whether it is helping you find the perfect team member, investment partner or connecting you with service providers, we have you covered.

With over two decades of Australian investment in building capability in research and universities, Australia now enjoys some of the most extraordinary talent and globally leading minds. This talent is creating knowledge and has the capacity of solving some of the big problems of our time but if we can’t take this know-how and intellect into the world, then this brilliance is lost and the opportunity we have will remain just that – an opportunity. As business builders and investors, Significant has been taking up this challenge for nearly two decades. Working in collaboration with universities, researchers and state governments, we, as a collective group have a track record in translating this knowledge bank into technology, into products, into services and ultimately into businesses that: Have become global companies Re-shaped markets Solved sustainability problems Created jobs and New career pathways for Australians Significant has the capacity to create high value niche modern manufacturing industries and exports for Australia and are extremely proud of their achievements. Significant leads by example to show that Australia can commercialise its inventions, that sustainable globally competitive businesses can be created in Australia, and that early-stage investment can create immense value for investors, demonstrating that through action Significant is able to attract more capital to invest in this important space and is be able to shift the mindset (read the AFR article) that Australia is great at innovation but not at execution. Backing Australia Our vision is a country that backs its researchers for the intellectual capital advantage they provide. Our mission is to back this talent, entrepreneurs and innovators to take these ideas and concepts to the world and create its own self-funding eco-system that results in the formation of new industries. Through our 4-way all-encompassing unique eco-system, our university investor partners provide us with access to the ‘very earliest’ investment opportunities possible, opening the door to concepts, ideas and innovations well before other venture capital funds. Our investment approach We invest in applied technologies that address high-impact global niche markets and will bring about social, environmental or economic change. Every potential investment must have a pathway to being a sustainable business and contributing impact to the UN Sustainable Development Goals either through the technology or through their business model. We look for technologies that provide a market advantage that is hard to replicate. They will have emerged either from researchers who have had long well-funded R&D cycles or innovators who have deep domain specialisation in an industry and so know their market problem exceptionally well. We are sector agnostic driven by the thematics that arise from the core capabilities of our partner universities and the innovations we uncover. The accelerators Strong market-fit and early industry engagement are imperative. We seek to accelerate the path to market dramatically by sourcing early adopters to validate the market need and aim to achieve market traction within 12-24 months. Our ability to find these early adopters is a key part of Significant’s initial due diligence.

RRW invests in outstanding European Tech companies. We promote their international take-off by providing significant financial firepower and game changing hands-on support in Europe & the US. Backing EU talents in the US Red River West was created to bring active support to outstanding European Tech Companies that have something unique to bring to the US market and transform them into US and Global successes. Within the team, we all share a track record of building and backing start-ups which became global leaders through EU to US expansion. We see our mission of backing European talents into US and Global successes as of strong impact. Europe is indeed home to a talented, driven pool of highly educated engineers and creative entrepreneurs. But the unfamiliarity with the US market means that too many promising European start-ups do not realize their full potential. US success doesn’t just mean bigger scale and more capital: translating Europe-based talent into US success requires expertise, commitment, and a deep understanding of the different business cultures. Narrow, hands-on portfolio strategy In the way we operate as investors and partners, we fully align with the success of the entrepreneurs we back. We have indeed a narrow portfolio strategy : we invest in only circa 10 companies per fund. It makes it possible for our team to dedicate plenty of time to the success of each entrepreneurs and truly provide game-changing hands-on support on both continents. This approach is really unique in VC and those differentiated foundations have been driving and fuelling our operating and ESG approach since day 1. Real-world impact We see our mission of backing European talents into US and Global successes as of strong impact by design. Europe is indeed home to talented and driven pool of top engineers and creative entrepreneurs, but they too often miss the familiarity needed with the US to scale globally. Additionally, we believe the Tech segments & models we invest in present huge opportunities to serve ESG global concerns, therefore investing in founders that care about their impact is one of our 5 core investment criteria. We have integrated environmental, social and governance best practices in numerous aspects of our own organization, including our proprietary sourcing platform. Bringing support on three ESG pillars Our latest fund RRW II Growth is classified under Article 8 of SFDR regulation, as a financial product that promotes, among other things, environmental or social characteristics. We decided to focus our efforts on three ESG subjects: Ethical Technology People Well-being Carbon Reduction We are convinced that those challenges fully align with our performance as a leading EU to US Tech investor; and this is our differentiated narrow portfolio strategy and operating DNA that allows us to act as dedicated and impactful partners on those three ESG pillars.

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ unique strategy combines early-stage investments in promising startups and strong entrepreneurial support to enable and strengthen the company’s growth. As an early-stage investor, we act as a catalyst to create companies based on innovations coming from academic research. We have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of strong network of scientific, clinical, industry and financial partners. The operational team is managed by Alain Huriez, MD, Chairman and Managing Partner, and Geoffroy de Ribains, Managing Partner. The team includes seasoned investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific, medical and operational expertise.

VII Ventures is a venture capital group investing in entrepreneurs that are accelerating a shift towards a more sustainable and circular economy. We have a proven track-record of nurturing companies and providing our investors with superior returns on their capital. Our strategy is built on putting together diversified portfolios of technology-based ventures led by winners in their segments and supporting those investments through to a successful exit. Our passion is finding those winning companies that focus on solving complex problems. This can be anything from leveraging technology in India’s grocery market through to the production of melanin to produce new energy sources. We help these start-ups by developing long-term strategies that support ambitious growth and create lasting value. Our global portfolio includes companies in the U.S, India, Canada and Europe. The firm has three General Partners and to date has invested in more than 14 leading start-ups. Our Model Invest in winners: Through our seasoned leadership team and robust due diligence, we identify and invest in those companies that have potential to become winners in their segments. Help them scale: We help these companies refine and productize their offering to expand into new markets. We advise Boards and CEOs on making key strategic decisions, defining growth strategies, and attracting other global investors. Successful exit: Every start-up is different, and an exit strategy will always depend highly on the situation. We will work with the company to identify the best exit event including mergers and acquisitions (M&A), initial public offering (IPO), and private offering (Secondary exits).